Neurogene
$20.22
14
-$1.44-6.65% Today
Statistics
Day High
22.08
Day Low
19.87
52W High
37.27
52W Low
6.88
Volume
54,264
Avg. Volume
167,262
Mkt Cap
313.21M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-1.354286
Actual EPS
N/A
Financials
-8,123.68%Profit Margin
Unprofitable1.85MRevenue
-150.29MNet Income
Analyst Ratings
$106.67Average Price Target
The highest estimate is 200.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NGNE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Show more...
CEO
Dr. Rachel L. McMinn Ph.D.
Employees
107
Country
US
ISIN
US64135M1053
Listings
0 Comments
Share your thoughts
FAQ
What is Neurogene stock price today?▼
The current price of NGNE is $20.22 USD — it has decreased by -6.65% in the past 24 hours. Watch Neurogene stock price performance more closely on the chart.
What is Neurogene stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neurogene stocks are traded under the ticker NGNE.
Is Neurogene stock price growing?▼
NGNE stock has fallen by -5.51% compared to the previous week, the month change is a -2.46% fall, over the last year Neurogene has showed a +93.4% increase.
What is Neurogene market cap?▼
Today Neurogene has the market capitalization of 313.21M
When is the next Neurogene earnings date?▼
Neurogene is going to release the next earnings report on May 08, 2026.
What were Neurogene earnings last quarter?▼
NGNE earnings for the last quarter are -0.99 USD per share, whereas the estimation was -1.25 USD resulting in a +20.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Neurogene revenue for the last year?▼
Neurogene revenue for the last year amounts to 1.85M USD.
What is Neurogene net income for the last year?▼
NGNE net income for the last year is -150.29M USD.
How many employees does Neurogene have?▼
As of April 02, 2026, the company has 107 employees.
In which sector is Neurogene located?▼
Neurogene operates in the Health Care sector.
When did Neurogene complete a stock split?▼
The last stock split for Neurogene was on December 19, 2023 with a ratio of 1:4.
Where is Neurogene headquartered?▼
Neurogene is headquartered in New York, US.